REQUEST A DEMO
Total
USD $0.00
Search more companies

Angia Rx Life Science Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Angia Rx Life Science Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Angia Rx Life Science Private Limited is an unlisted company, incorporated on 11/06/2019. It has its registered office in the State of Uttarakhand, India. Company's corporate identification number (CIN) is U24234UR2019PTC009892 and registration number is 009892. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
19-B, 1St Floor, Pushotam Residency, Sunehra
Haridwar; Uttarakhand; Postal Code: 247667

Contact Details: Purchase the Angia Rx Life Science Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Angia Rx Life Science Private Limited report to view the information.
Outstanding Shares:
Purchase the Angia Rx Life Science Private Limited report to view the information.
Registered Capital:
Purchase the Angia Rx Life Science Private Limited report to view the information.
Incorporation Date:
June 11, 2019
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Angia Rx Life Science Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
49.15%
Total operating revenue
49.29%
Operating profit (EBIT)
52.47%
EBITDA
37.28%
Net Profit (Loss) for the Period
57.22%
Total assets
63.42%
Total equity
100.51%
Operating Profit Margin (ROS)
0.04%
Net Profit Margin
0.1%
Return on Equity (ROE)
-13.8%
Debt to Equity Ratio
31.17%
Quick Ratio
0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?